LLY

992.23

+0.48%↑

JNJ

224.08

-0.79%↓

ABBV

205.44

-0.58%↓

UNH

367.84

+1.31%↑

AZN

185.21

+2.03%↑

LLY

992.23

+0.48%↑

JNJ

224.08

-0.79%↓

ABBV

205.44

-0.58%↓

UNH

367.84

+1.31%↑

AZN

185.21

+2.03%↑

LLY

992.23

+0.48%↑

JNJ

224.08

-0.79%↓

ABBV

205.44

-0.58%↓

UNH

367.84

+1.31%↑

AZN

185.21

+2.03%↑

LLY

992.23

+0.48%↑

JNJ

224.08

-0.79%↓

ABBV

205.44

-0.58%↓

UNH

367.84

+1.31%↑

AZN

185.21

+2.03%↑

LLY

992.23

+0.48%↑

JNJ

224.08

-0.79%↓

ABBV

205.44

-0.58%↓

UNH

367.84

+1.31%↑

AZN

185.21

+2.03%↑

Search

Rhythm Pharmaceuticals Inc

Open

BrancheGesundheitswesen

96.15 17.7

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

81.69

Max

96.46

Schlüsselkennzahlen

By Trading Economics

Einkommen

5.4M

-48M

Verkäufe

6M

57M

Gewinnspanne

-82.974

Angestellte

414

EBITDA

5.1M

-43M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+59.18% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-565M

5.9B

Vorheriger Eröffnungskurs

78.45

Vorheriger Schlusskurs

96.15

Nachrichtenstimmung

By Acuity

62%

38%

301 / 347 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

Rhythm Pharmaceuticals Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. Mai 2026, 23:43 UTC

Wichtige Nachrichtenereignisse

New Zealand's Unemployment Rate Falls in 1Q

5. Mai 2026, 23:20 UTC

Heiße Aktien

Stocks to Watch: AMD, Super Micro, Arista Networks, Freshworks

5. Mai 2026, 21:48 UTC

Ergebnisse

Suncor Energy Reports Higher 1Q Profit on Increased Oil Production

5. Mai 2026, 21:05 UTC

Akquisitionen, Fusionen, Übernahmen

Canada Antitrust Watchdog Seeks to Kibosh Keyera Deal for Plains' Canada Gas Business -- 4th Update

6. Mai 2026, 00:00 UTC

Market Talk

Canada Energy Minister Signals Energy Investments in the Pipeline -- Market Talk

5. Mai 2026, 23:39 UTC

Market Talk

Gold Rises; Trump Pauses 'Project Freedom' to See if Iran Deal Can Be Finalized -- Market Talk

5. Mai 2026, 22:26 UTC

Market Talk

AMD Data-Center Business Continues to Surge -- Market Talk

5. Mai 2026, 22:20 UTC

Market Talk

AMD's AI Revolution is Still in Early Innings, Analysts Say -- Market Talk

5. Mai 2026, 22:08 UTC

Ergebnisse

Correction to "Palantir Beats Forecasts" on May 4. -- WSJ

5. Mai 2026, 22:07 UTC

Ergebnisse

AMD Stock Soars on Strong Earnings and Growing Confidence About AI -- Barrons.com

5. Mai 2026, 21:48 UTC

Ergebnisse

Pan American Silver 1Q Adj EPS $1.09 >PAAS

5. Mai 2026, 21:48 UTC

Ergebnisse

Pan American Silver 1Q Rev $1.2B >PAAS

5. Mai 2026, 21:42 UTC

Ergebnisse

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

5. Mai 2026, 21:38 UTC

Ergebnisse

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

5. Mai 2026, 21:30 UTC

Ergebnisse

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

5. Mai 2026, 21:29 UTC

Ergebnisse

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

5. Mai 2026, 21:26 UTC

Ergebnisse

Strategy Posts Wider Loss as Bitcoin Holdings Hit $64 Billion. The Stock Falls. -- Barrons.com

5. Mai 2026, 21:25 UTC

Ergebnisse

Alcon Inc. 1Q EPS 39c >ALC.EB

5. Mai 2026, 21:25 UTC

Ergebnisse

Alcon Inc. 1Q Rev $2.71B >ALC.EB

5. Mai 2026, 21:24 UTC

Ergebnisse

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

5. Mai 2026, 21:18 UTC

Ergebnisse

Mistras Backs 2026 Rev $730M-$750M >MG

5. Mai 2026, 21:17 UTC

Ergebnisse

AMD Stock Jumps on Solid Earnings. AI Continues to Drive Data Center Chips. -- Barrons.com

5. Mai 2026, 21:15 UTC

Ergebnisse

Strategy Records Loss of Nearly $13 Billion as Bitcoin Continues Decline -- WSJ

5. Mai 2026, 21:12 UTC

Ergebnisse

These Stocks Are Today's Movers: Intel, PayPal, Palantir, Shopify, Micron, Duolingo, and More -- Barrons.com

5. Mai 2026, 21:11 UTC

Ergebnisse

SSR Mining 1Q Rev $581.8M >SSRM

5. Mai 2026, 21:10 UTC

Ergebnisse

SSR Mining 1Q Adj EPS $1.15 >SSRM

5. Mai 2026, 21:10 UTC

Ergebnisse

SSR Mining 1Q EPS $1.16 >SSRM

5. Mai 2026, 21:08 UTC

Ergebnisse

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

5. Mai 2026, 21:01 UTC

Ergebnisse

Intact Financial 1Q EPS C$4.12 >IFC.T

5. Mai 2026, 21:01 UTC

Heiße Aktien

Stocks to Watch Recap: Palantir, AMD, Intel, HSBC -- WSJ

Peer-Vergleich

Kursveränderung

Rhythm Pharmaceuticals Inc Prognose

Kursziel

By TipRanks

59.18% Vorteil

12-Monats-Prognose

Durchschnitt 136.23 USD  59.18%

Hoch 158 USD

Tief 105 USD

Basierend auf 14 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Rhythm Pharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

14 ratings

14

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

60 / 65.58Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bullish Evidence

Stimmung

By Acuity

301 / 347 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
help-icon Live chat